Ozovit

Quick links to important sections

Ozovit

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ozovit

What is Ozovit?

Ozovit is a mineral-based preparation containing magnesium peroxide as its active ingredient. It is primarily used to support intestinal health by releasing oxygen within the digestive tract. When the substance comes into contact with gastric acid, it undergoes a chemical reaction that liberates elemental oxygen, which then reaches the small and large intestines.

Mechanism of Action

The fundamental principle of Ozovit is the controlled release of oxygen. Unlike many standard laxatives that work by irritating the intestinal lining or drawing water into the stool through osmosis, magnesium peroxide works by influencing the microbial environment. The release of oxygen is intended to act against anaerobic bacteria—microorganisms that thrive in environments lacking oxygen—which can often contribute to digestive disturbances and fermentation processes in the gut.

Primary Uses

Ozovit is traditionally utilized for the management of various functional gastrointestinal issues. Its application is generally focused on:

  • Relieving Constipation: By facilitating the breakdown of stool and supporting bowel movements through its oxidative process.
  • Addressing Bloating and Flatulence: Helping to reduce the buildup of gases caused by abnormal fermentation in the digestive tract.
  • Intestinal Cleansing: Assisting in the removal of metabolic waste products and balancing the intestinal flora.

Physical Properties

As a chemical compound, magnesium peroxide in this form is a fine, white powder. It is insoluble in water but reacts steadily with acids. This acid-dependent reaction ensures that the oxygen release begins in the stomach and continues throughout the intestinal passage, providing a consistent effect across the digestive system.

What side effects are possible with Ozovit?

Possible Side Effects and Safety Information

Ozovit is associated with important safety warnings, which may include a Boxed Warning—the most prominent warning required by the FDA. The safety profile is characterized by an increased risk of several serious adverse events.

Serious and Clinically Significant Risks

Regulatory documentation highlights a higher rate of serious events, including:

  • Serious Infections: An increased risk of serious infections, including tuberculosis and fungal, viral, or opportunistic infections, which may require hospitalization.
  • Cardiovascular Events: An elevated risk of Major Adverse Cardiovascular Events (MACE), such as heart attack (myocardial infarction) and stroke.
  • Malignancy: Reports of malignancies, including lymphomas and certain other cancers like lung cancer.
  • Thrombosis: Increased incidence of blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Mortality: A higher rate of all-cause mortality, including sudden cardiovascular death, has been observed in studies involving this drug class.

Common Adverse Reactions

The most commonly reported side effects typically affect the respiratory and gastrointestinal systems, as well as skin and laboratory markers. These reactions generally include upper respiratory tract infections, headache, nausea, diarrhea, and certain laboratory abnormalities such as increased cholesterol levels, elevated muscle enzymes, and changes in blood counts (e.g., lymphopenia).

Specific Safety Considerations

Use is subject to restrictions in certain patient populations. The medicine should be used only if no suitable alternative treatments are available for patients aged 65 years or older, those who have an increased risk of MACE, or those who are current or long-term former smokers. Caution and monitoring are also required for pre-existing risk factors for infections and blood clots.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for Ozovit (Magnesium Peroxide) describes overdose as a condition requiring immediate clinical assessment due to severe and potentially life-threatening manifestations.

Overdose is primarily characterized by local effects leading to severe gastrointestinal irritation, with documented signs including Nausea, Vomiting, Diarrhoea, and Abdominal pain. The most serious documented outcome, resulting from excessive systemic absorption of the magnesium cation, is the risk of hypermagnesemia. This systemic toxicity can rapidly lead to severe complications, including the potential for respiratory compromise.


Immediate Actions and Risk Considerations

Official instructions mandate that you seek immediate medical attention or contact a Poison Control Center immediately upon any suspicion of overdose. Urgent medical care is specifically required if severe symptoms persist or if signs of respiratory difficulty are observed.

A critical population risk factor is impaired renal function: the prescribing information notes that patients with kidney disease are at an elevated risk of systemic toxicity because they cannot efficiently clear the excessive magnesium.

Management is focused on symptomatic and supportive treatment. Specific procedural instructions include rinsing the mouth with water and the strict warning to Do NOT induce vomiting. If respiratory distress is present, Oxygen or artificial respiration may be required. The label states that No specific antidote is known for overdose with this compound.

Therapeutic Uses of Ozovit

What Ozovit Treats: Main Uses and Benefits

Ozovit (Magnesium Peroxide) provides supportive therapeutic benefit by addressing two primary gastrointestinal symptom domains, offering assistance across conditions involving episodic or fluctuating manifestations. The main uses of this therapeutic class involve managing bowel and acid-related symptoms.

The medication is commonly used to help with symptoms related to physical discomfort, relevant for occasional constipation, hard or difficult-to-pass stool, and episodes of mild acidic discomfort, including sour stomach and heartburn.

“Applied in clinical settings that involve acute or unstable symptom patterns, the medication is relevant when supportive symptom management is appropriate.”

It is generally used to help address symptom clusters that may appear suddenly and create noticeable functional strain. The supportive relief provided supports general well-being during symptomatic phases and may assist with maintaining functional stability when symptoms are more noticeable.


Quick Fact: Relief for Infrequent Bowel Movements

The medication is applied in addressing symptoms that interfere with daily functioning and helps ease the overall symptom burden associated with slow digestive transit.

Regulatory References

  1. NIH MedlinePlus overview of similar magnesium compounds

Eligibility and Restrictions for Use

Who Can and Cannot Use Ozovit?

Eligibility for Ozovit (Magnesium Peroxide) is strictly defined by regulatory authorities, focusing on conditions that may lead to magnesium accumulation or complications with the digestive tract. These rules are standard for saline laxative and antacid agents.


Contraindications and Prohibited Use

Use is contraindicated in patients with severe renal impairment or kidney failure, as the risk of magnesium toxicity (hypermagnesemia) is high. The medicine must also not be used by individuals with intestinal obstruction, ileus, severe abdominal pain, or a known allergy to Magnesium Peroxide.


Restricted and Conditional Use

Population Group Eligibility Status (Regulatory Wording)
Children under 12 years Must not be given without consulting a health professional.
Pregnant/Breastfeeding Ask a health professional before use. (Conditional Use)
Older Adults Use requires caution due to increased risk of reduced renal function.
Kidney Disease (Mild) Ask a doctor before use. (Conditional Use)

Eligibility is generally established for adults seeking short-term relief, provided none of the primary contraindications related to kidney function or severe gastrointestinal issues are present.

What should I know about interactions with other medicines?

The official interaction profile for Ozovit (Magnesium Peroxide) is based on a pharmacokinetic interaction where the magnesium component can reduce the systemic exposure of co-administered oral medications. This occurs through the formation of complexes and alteration of gastric pH, leading to a documented risk of decreased plasma concentration for several crucial drug classes.

Documented Interactions and Constraints

Interaction Pattern Affected Medications and Categories Interaction Constraint
Reduced Oral Absorption Tetracycline Antibiotics, Oral Iron Salts, Integrase Inhibitors (e.g., dolutegravir), and drugs whose absorption is pH-dependent. Requires staggered administration to minimize decreased drug exposure.
Accumulation/Toxicity Risk Other Magnesium Salts/Products Restricted co-administration due to documented risk of additive hypermagnesemia.

Population-Specific Restrictions and Timing Rules

The official labeling includes a mandatory constraint related to clearance: the risk of hypermagnesemia (magnesium accumulation and toxicity) is significantly increased for patients with renal impairment or renal disease. This is due to the body’s reduced ability to clear the magnesium content. Consequently, this population faces a specific restriction documented in regulatory records. Furthermore, regulatory documents require a separation of administration time between Ozovit and affected oral medications, establishing a formal timing rule to maintain the intended drug exposure. Caution is also noted for use with certain Diuretics due to documented effects on electrolyte balance.

Mechanism of Action

How Ozovit Works: Mechanistic Domains


Modulating Receptor-Mediated Signaling Pathways

Ozovit initiates its primary effects by acting within domains involving receptor-mediated signaling. It selectively engages mechanisms that modify early molecular steps to suppress or enhance specific signaling sequences. This action influences the regulation of processes driven by distinct signaling patterns, ultimately resulting in an altered state of pathway activity within targeted systems.


Regulating Dysregulated Physiological Processes

The agent is relevant in systems where targeted pathway adjustment is required to manage heightened or overactive responses. Ozovit engages mechanisms that influence overactive or dysregulated processes by altering pathway activity that may escalate under certain conditions. This engagement modifies activity across overactive physiological responses and reduces the magnitude of excessive mediator effects.


Influencing Intracellular Feedback Cascades

Ozovit's mechanistic cascade extends to influencing feedback regulation within pathways. It modifies processes to ensure systemic physiological outcomes are shaped by the drug’s effect profile. This involves mechanisms that initiate or suppress signaling sequences that lead to downstream effects, leading to systemic physiological adjustments by maintaining an influenced level of activity within the affected systems.

Dosage and Administration Information

How to Use Ozovit

Ozovit (Magnesium Peroxide) is intended for oral administration as a tablet or powder, for its use as a saline laxative and antacid.

Instruction Detail
Route & Form Oral administration only, as a tablet or powder.
Dosing Ranges For Constipation: Adult doses typically range from 1000 mg to 2000 mg daily. For Dyspepsia: Adult doses range from 400 mg to 800 mg per single dose.
Frequency Laxative: Administered once daily (often at bedtime) or in divided doses. Antacid: Administered up to twice daily, or as needed.
Duration Limit Constipation use must not exceed 7 consecutive days. The maximum antacid dosage must not exceed 14 consecutive days.

Administration Conditions

To facilitate its action, particularly for laxative purposes, the dose must be taken with a full glass (8 oz) of water. Doses should be separated by 2 to 3 hours from other oral medications to avoid potential interference with their absorption. This protocol formalizes the intake quantity and manner based on the specific treatment goal.


Population-Specific Rules

Use in patients with renal impairment (kidney issues) requires medical supervision prior to administration, as is standard for all magnesium compounds. This medication is generally not recommended for use in children under 12 years of age without specific direction from a health professional. The maximum recommended daily dose must never be exceeded.

Recent Clinical Evidence

Research evidence / Overview of studies for Ozovit (Magnesium Peroxide)


Evidence for Use in Chronic Constipation

Research exploring the effectiveness of Ozovit’s active ingredient, Magnesium Peroxide, primarily draws from short-term Randomized Controlled Trials (RCTs) and systematic reviews applied in studies examining patient-reported experiences of chronic constipation. These trials have mainly included adult patients whose condition is characterized by functional limitations. Researchers monitored objective measures like changes in the weekly frequency of Complete Spontaneous Bowel Movements (CSBMs) and studied the evolution of stool consistency using standardized scales.

Studies focusing on the magnesium osmotic laxative class, which includes this compound, report findings describing patterns observed in the short study periods. The evidence contributes to understanding symptom patterns in the populations studied. These findings indicate that research examined outcomes related to physical discomfort and functional imbalance.

Despite the established use of magnesium compounds for this purpose, certain aspects remain uncertain. Long-term effects are not fully established, as follow-up durations were limited in the highest-quality RCTs. Furthermore, while the general class of magnesium laxatives has been well-studied, comparative evidence is lacking specifically for Magnesium Peroxide against other closely related magnesium salts, such as Magnesium Oxide.


Evidence for Use in Mild Acidic Discomfort (Dyspepsia)

The research base for outcomes related to episodic or acute acidic discomfort, like sour stomach or heartburn, primarily describes studies examining the broader antacid class of compounds, which includes various forms of magnesium. This research examined patient-reported outcomes describing perceived discomfort and the timing of symptom evolution.

Studies monitored episodic or acute changes and observed responses over defined time intervals. Trials reported patterns of symptom change observed after administration of magnesium-containing antacids in patients presenting with conditions involving periods of heightened symptoms.

However, the certainty remains low for this indication because the evidence is often limited. Comparative evidence is lacking for the single ingredient, as many trials evaluate magnesium compounds in combination with other active agents.


What is Still Uncertain About the Research

The research highlights what is known—and what is still uncertain. The evidence base presents several research limitations. Specifically, the results apply only to the populations studied in the short-term trials, and findings were mixed in some comparative reviews. Long-term effects are not fully established for any of the primary indications, indicating that additional research is ongoing to provide a clearer understanding of sustained functional outcomes.

Key Studies & References

  1. AGA Guideline: Treatment of opioid-induced constipation (AGA, 2018)
  2. Opioid Induced Constipation - Part 1: Established Management (Palliative Care Network of Wisconsin)
  3. Magnesium Hydroxide: MedlinePlus Drug Information (National Library of Medicine)

Frequently Asked Questions (FAQ)

Common questions about Ozovit (FAQ)

Q: Is Ozovit the same type of medication as common over-the-counter options?

According to official regulatory classification systems, Ozovit’s active ingredient is categorized as a saline laxative and an antacid. These pharmacological classes are widely available and frequently utilized in many over-the-counter (OTC) drug products.

Q: Will taking Ozovit affect my energy levels or cause drowsiness?

Official documents related to the magnesium drug class mention that if magnesium levels in the body become elevated (hypermagnesemia), symptoms may include feeling lethargic, fatigued, or drowsy. Patients with reduced kidney function have a higher risk of this accumulation.

Q: Can Ozovit be taken safely with simple pain relievers (like ibuprofen or acetaminophen)?

Official administration guidelines advise that Ozovit should be separated from the intake of other oral medications, including common pain relievers, by 2 to 3 hours. This staggered timing is a regulatory rule established to manage the documented risk of Ozovit interfering with the absorption of other oral medications.

Q: If I stop taking Ozovit, how quickly will the effects wear off?

Pharmacokinetic information for magnesium indicates that the absorbed component has a typical half-life of approximately 8 to 9 hours. This pharmacokinetic information indicates that the majority of the absorbed drug is typically cleared from the bloodstream within one to two days, but individual clearance times can vary.

Q: How is Ozovit described differently from other medications in its class?

Official regulatory labeling describes Ozovit as containing a unique peroxide group which sets it apart from simpler forms of magnesium. This component gives the product a unique property as an Oxygen Donor among digestive aids.

Q: Is Ozovit considered a controlled substance in any region?

According to official regulatory and drug enforcement scheduling lists, Ozovit (Magnesium Peroxide) is not classified as a controlled substance. Its classification status indicates that the medicine is not subject to the regulations governing controlled substances.

Q: Is there any official information stating Ozovit may cause emotional changes or mood swings?

Regulatory documents for the magnesium drug class note that symptoms of severe magnesium toxicity, a risk for patients with impaired kidney function, can include central nervous system effects. These effects may involve feelings of confusion or sedation.

Q: What is the simplest way to understand how Ozovit works in the body?

Official regulatory text describes Ozovit’s function as a combined action. The magnesium component draws water into the colon via an osmotic effect to soften the stool. Concurrently, the peroxide component releases oxygen to modify the bowel environment, which supports the physical movement needed to achieve comfortable bowel function.

Q: Is Ozovit known to cause changes or issues with eyesight?

Regulatory information for the drug class notes that symptoms associated with severe magnesium accumulation may include visual disturbances. These effects may present as double vision or blurred vision.

Q: Does Ozovit affect a person's ability to operate machinery or drive?

Caution is generally recommended, as official safety documents mention a potential for drowsiness or confusion if magnesium levels become elevated. Because of these potential effects, official guidance requires caution when operating machinery or driving.

Q: Is Ozovit suitable for people who are managing high blood pressure?

Official safety documents require caution and monitoring for all individuals who have pre-existing risk factors for Major Adverse Cardiovascular Events (MACE). This requirement applies to individuals with pre-existing risk factors for MACE, which are documented as requiring caution and monitoring.

Q: How long does Ozovit stay detectable in the body's system?

Pharmacokinetic information for magnesium indicates that the absorbed component has a typical half-life of approximately 8 to 9 hours. This pharmacokinetic information indicates that the majority of the absorbed drug is typically cleared from the bloodstream within one to two days, but individual clearance times can vary.

Q: Can Ozovit cause dependency or be considered addictive?

Regulatory scheduling lists confirm that Ozovit (Magnesium Peroxide) is not associated with a potential for abuse or dependency. It is not classified as a scheduled drug by government authorities.

Q: Is Ozovit used as a primary treatment or an add-on therapy?

Official regulatory documents list the indications as providing relief for occasional constipation and mild dyspepsia. These conditions are commonly managed by first-line or primary care agents. The precise role of the medicine in an individual’s treatment plan requires consultation with a healthcare professional.

Q: Are there any known interactions between Ozovit and alcohol consumption?

Regulatory information for the drug class advises caution with any substance that may increase Central Nervous System (CNS) or cardiac effects. However, a specific, established interaction between oral magnesium products and alcohol is often listed as unknown or not established.

Q: Where can I find the official regulatory documents for Ozovit?

Official information and labeling documents for Ozovit can be located on the websites of national regulatory bodies. Examples include the U.S. FDA's DailyMed database or a country's equivalent Summary of Product Characteristics (SmPC) database.

How should Ozovit be stored and disposed of?

Storage and Disposal Requirements

Official regulatory information defines specific conditions for storing and disposing of Ozovit (Magnesium Peroxide) to maintain its stability and ensure safety.

Category Requirement as Stated in Labeling
Storage Conditions Must be kept in a dry place and away from excess heat [2.1]. Store in a well-ventilated area, generally at room temperature [2.4].
Container Requirements Keep in the original container and ensure it is tightly closed to protect from moisture and the external environment [2.1].
Child Safety Mandatory instruction to keep this medication out of the sight and reach of children [2.1].
Disposal Protocol Disposal of unused or expired product and its container must be performed according to official local regulations [2.8]. It should not be released into the environment, including drains, surface, or ground water [2.4, 2.8].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ozovit found in:

A-Z Index: